A Clinical Study to Evaluate the Effect of Ayurvedic Treatment (Eranda Oil Matra Basti and Chandraprabha Vati) in Patients with Enlarged Prostate

EFFICACY OF ERANDA TAILA MATRA BASTI AND CHANDRAPRABHA VATI IN THE MANAGEMENT OF VATASHTEELA (BENIGN PROSTATIC HYPERPLASIA)- AN OPEN LABEL SINGLE ARM CLINICAL TRIAL - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/105765

Enrollment

Registered

2026-03-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with Age group between 40 years to 80 years. 2.Patients with American urology association (AUA) symptom score greater than 8 and less than21 3) Rectal examination consistent with Benign Prostatic Hyperplasia 4. Prostate volume grater than 20cc 5. Prostate specific antigen lesser than 4ng per ml 6. Willing and able to participate in the study for 4 weeks

Exclusion criteria

Exclusion criteria: 1.Age of below 40yrs and above 80yrs. 2.Patients with history of Trans urethral resection of the prostate 3.Patient with known case of Serum prostate specific antigen greater than 4ng/ml 4.Patient with known case of Chronic retention of urine .post void urine volume more than 150ml 5.Patients with known case of evidence of malignancy 6.Patients with known case of poorly controlled Type2 Diabetic mellitus .HBA1C greater than 10 percent 7.Patients with Known case of poorly controlled hypertension 8. Patients on prolonged.more than 6weeks medication with corticosteroids, anticholinergics or any other drugs that may have an influence on the outcome of the study 9.Patient with known case of Severe urinary calculi with significant to obstructive uropathy, Renal failure 10.Patients suffering from major systemic illness necessitating long term drug treatment

Design outcomes

Primary

Measure	Time frame
Primary Outcome Change in International Prostate Symptom Score before and after treatment to evaluate the improvement in clinical signs and symptoms of Vatashteela following administration of Eranda Taila Matra Basti and Chandraprabha Vati.Timepoint: 28days	—

Secondary

Measure	Time frame
Secondary Outcomes Change in Post Void Residual (PVR) urine volume measured by ultrasonography before and after the intervention. Change in Prostate Size (Prostate Volume) measured by ultrasonography before and after treatment. Improvement in Quality of Life (QOL) score related to urinary symptoms assessed before and after the interventionTimepoint: 28days	—

Countries

India

Contacts

Public ContactArchana

Sri Dharmasthala Manjunatheshwara college of ayurveda and hospital,hassan

drgopiboyapati@gmail.com9886360901

Outcome results